New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
13:25 EDTFLDM, FLDM, FLDM, GNOM, GNOM, GNOM, ILMN, ILMN, ILMN, LIFE, LIFE, LIFE, ONT, ONT, ONT, PACB, PACB, PACBLeerink's life science tools and diagnostics analyst to hold a conference call
Life Science Tools & Diagnostics Analyst Leonard provides an update on the DNA sequencing landscape including ILMN’s new HiSeq capability, LIFE’s Ion Proton and PGM, desktop sequencing demand and the funding environment for nextgen sequencing. Relevant companies FLDM, GNOM, ILMN, LIFE, ONT and PACB may be included on the Analyst/Industry conference call to be held on January 24 at 2 pm.
News For FLDM;GNOM;ILMN;LIFE;ONT;PACB From The Last 14 Days
Check below for free stories on FLDM;GNOM;ILMN;LIFE;ONT;PACB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
10:56 EDTILMNOptions with decreasing implied volatility: CMG MTG VRX ILMN
Subscribe for More Information
10:01 EDTILMN, FLDMOn The Fly: Analyst Upgrade Summary
A.O. Smith (AOS) upgraded at BMO Capital... Agnico-Eagle (AEM) upgraded to Outperform from Sector Perform at RBC Capital... Allergan (AGN) upgraded to Overweight from Neutral at JPMorgan... Cabot Oil & Gas (COG) upgraded to Buy from Hold at Societe Generale... Cree (CREE) upgraded to Buy from Hold at Summit Research... E-Trade (ETFC) upgraded to Outperform from Market Perform at Wells Fargo... Equifax (EFX) upgraded at Credit Suisse... Fluidigm (FLDM) upgraded to Buy from Neutral at Mizuho... GlaxoSmithKline (GSK) upgraded to Buy from Hold at Argus... GulfMark Offshore (GLF) upgraded to Buy from Neutral at Global Hunter... Hanmi Financial (HAFC) upgraded to Outperform from Market Perform at Fig Partners... Illumina (ILMN) upgraded to Buy from Hold at Maxim... Lumber Liquidators (LL) upgraded to Buy from Neutral at Longbow... Medidata Solutions (MDSO) upgraded to Buy from Neutral at B. Riley... Prologis (PLD) upgraded to Buy from Neutral at ISI Group... Sanmina (SANM) upgraded to Buy from Hold at Craig-Hallum... SunPower (SPWR) upgraded to Buy from Hold at Deutsche Bank... TECO Energy (TE) upgraded to Neutral from Sell at UBS... Torchmark (TMK) assumed with a Market Perform from Underperform at Keefe Bruyette... Valeant (VRX) upgraded to Buy from Hold at TD Securities... Vitamin Shoppe (VSI) upgraded at Sterne Agee... Wolseley (WOSYY) upgraded to Outperform from Neutral at Credit Suisse... athenahealth (ATHN) upgraded to Overweight from Equal Weight at Morgan Stanley.
09:16 EDTILMNOn The Fly: Pre-market Movers
Subscribe for More Information
07:59 EDTILMNIllumina upgraded to Buy from Hold at Maxim
Subscribe for More Information
06:45 EDTILMNIllumina price target raised to $180 from $160 at Leerink
Subscribe for More Information
April 22, 2014
19:09 EDTILMNOn The Fly: After Hours Movers
Subscribe for More Information
17:24 EDTFLDMFluidigm upgraded to Buy from Neutral at Mizuho
Subscribe for More Information
16:22 EDTILMNIllumina trades higher after results, first look
In the extended session shares are trading up over 6% to $157. At that price, next resistance is at $159.72. Support is at $155.86.
16:14 EDTILMNIllumina raises FY14 EPS view to $2.10-$2.15, consensus $2.05
The company has increased projections to approximately 21% to 23% revenue growth, consensus $1.68B.
16:13 EDTILMNIllumina reports Q1 adjusted EPS 53c, consensus 44c
Subscribe for More Information
15:32 EDTILMNNotable companies reporting after market close
Subscribe for More Information
April 21, 2014
10:11 EDTILMNIllumina has a conference call hosted by JPMorgan
JPMorgan Analyst Peterson will host a conference call with CFO Marc Stapley on April 25 at 11 am.
07:58 EDTILMNIllumina May volatility elevated at 68 into Q1 and outlook
Subscribe for More Information
April 14, 2014
07:04 EDTFLDMFluidigm upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Fluidigm to Outperform citing reasonable consensus revenue estimates and strong demand for single cell gene expression analysis tools. The firm has a $52 price target for shares.
April 9, 2014
08:58 EDTILMNIllumina not targeted by new Chinese regulations, says Janney Capital
Subscribe for More Information
08:24 EDTFLDMPiper Jaffray's medtech analysts hold an analyst/industry conference call
The MedTech Analyst Team focuses on Piper Jaffray's covered universe from the perspective of Technical Analyst Johnson ahead of 1Q14 earnings results on an Analyst/Industry conference call to be held on April 11 at 10 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use